For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Institute of Cancer Research: Royal Cancer Hospital (the)

USPTO Granted Patents = 12

Forward Citations = 65

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Dan Niculescu-Duvaz (12 out of 26 patents)

Ion Niculescu-Duvaz (10 out of 16 patents)

Alfonso Zambon (10 out of 15 patents)

4. Richard Marais (10 out of 26 patents)

5. Caroline Joy Springer (10 out of 41 patents)

6. Delphine Menard (7 out of 11 patents)

7. Bartholomeus Marinus Josephus Marie Suijkerbuijk (4 out of 5 patents)

8. Arnaud Nourry (4 out of 6 patents)

9. Christopher Lord (2 out of 31 patents)

10. Alan Ashworth (2 out of 15 patents)

11. Romina Girotti (2 out of 2 patents)

12. Roderick Alan Porter (2 out of 2 patents)

13. Raymond John Boffey (2 out of 2 patents)

14. Melanie Jayne Bayford (2 out of 2 patents)

15. Stuart Firth-Clark (2 out of 2 patents)

12 patents: Sort by Forward Citations

1. 10167282 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2019-01-01),

2. 9820976 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2017-11-21),

3. 9725447 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2017-08-08),

4. 9611223 - 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use (2017-04-04),

5. 9540372 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2017-01-10),

6. 9439893 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2016-09-13),

7. 9193689 - 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use (2015-11-24),

8. 9155737 - Pyrido[2,3-B]pyrazin-8-substituted compounds and their use (2015-10-13),

9. 9120789 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2015-09-01),

10. 8912191 - Pyrido[2,3-B]pyrazin-8-substituted compounds and their use (2014-12-16),

11. 8383816 - Aryl-quinolyl compounds and their use (2013-02-26),

12. 8198279 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2012-06-12),

The Institute of Cancer Research: Royal Cancer Hospital is a world-leading cancer research organization dedicated to advancing the understanding and treatment of cancer. With a focus on personalized medicine and targeted therapies, the Institute is at the forefront of groundbreaking research that is transforming the field of oncology. Visit our website to learn more about our cutting-edge research and collaborative efforts in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#244 in London

#1,432 in United Kingdom

#46,665 in the World

London, United Kingdom

Institute of Cancer Research: Royal Cancer Hospital (the)

Forward Citations = 65

24 inventors:

Dan Niculescu-Duvaz (12 out of 26 patents)

Ion Niculescu-Duvaz (10 out of 16 patents)

Alfonso Zambon (10 out of 15 patents)

4. Richard Marais (10 out of 26 patents)

5. Caroline Joy Springer (10 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…